Synergistic Radiation Therapy System

Publication ID: 24-11857806_0008_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Synergistic Radiation Therapy System,” Published Technical Disclosure No. 24-11857806_0008_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857806_0008_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,806.

Summary of the Inventive Concept

A novel radiation therapy system integrating luminescence-based detection, artificial intelligence, IoT, blockchain, and novel materials to optimize and personalize cancer treatment.

Background and Problem Solved

Conventional radiation therapy often lacks precision and real-time monitoring, leading to unwanted side effects and ineffective treatment. The original patent introduced a luminescence-based method for precise delivery of ion beam therapy, but its limitations included the lack of real-time monitoring, personalized treatment planning, and secure data management. The new inventive concept addresses these limitations by synergistically combining distinct technologies to create a more powerful and effective radiation therapy system.

Detailed Description of the Inventive Concept

The Synergistic Radiation Therapy System comprises a luminescence-based marker for detecting ion beam radiation, an artificial intelligence module for analyzing luminescence data and optimizing radiation dosage, an IoT-enabled sensor network for real-time monitoring, a blockchain-based ledger for secure storage of patient treatment records, and a novel material-based luminescence detector. The system integrates machine learning algorithms to predict optimal radiation dosages, generates personalized radiation treatment plans based on patient-specific anatomy and tumor characteristics, and enables secure sharing of patient data and treatment plans among healthcare providers.

Novelty and Inventive Step

The new inventive concept introduces a synergistic combination of distinct technologies, including AI, IoT, blockchain, and novel materials, which provides a non-obvious solution to the limitations of conventional radiation therapy and the original patent. The integration of these technologies enables real-time monitoring, personalized treatment planning, and secure data management, resulting in a more effective and precise radiation therapy system.

Alternative Embodiments and Variations

Alternative embodiments of the Synergistic Radiation Therapy System could include variations in the type of luminescence-based marker, the specific AI algorithms used, the design of the IoT-enabled sensor network, and the materials used for the luminescence detector. Additionally, the system could be adapted for use in other medical treatments, such as proton therapy or brachytherapy.

Potential Commercial Applications and Market

The Synergistic Radiation Therapy System has significant commercial potential in the radiation oncology market, with potential applications in cancer treatment centers, hospitals, and research institutions. The system's ability to provide personalized and precise radiation therapy could lead to improved treatment outcomes, reduced side effects, and increased patient satisfaction, resulting in a significant market opportunity.

Field of Art

Radiation oncology and medical imaging technologies, with expertise in ion beam therapy, luminescence-based detection systems, and advanced medical treatment optimization techniques

Person of Ordinary Skill (PHOSITA) Profile

A medical physicist or biomedical engineer with advanced degrees, expertise in radiation therapy technologies, familiarity with AI and sensor integration, and understanding of medical data management systems

Obviousness Rationale

A PHOSITA would recognize that the PTD's integration of AI, IoT, and blockchain technologies represents a predictable extension of the source patent's luminescence-based radiation therapy approach. The core radiation therapy methodology remains fundamentally consistent with the original patent, while the additional technological layers provide incremental improvements in monitoring, personalization, and data management. These technological integrations represent well-known optimization strategies in medical treatment technologies.

Obvious Combinations & Variations

Source Patent Element
EUD4TEA-inclusive marker for detecting ion beam radiation placement
PTD Variation
AI-enhanced luminescence marker with machine learning-powered analysis of radiation detection
Obviousness Reasoning
Applying machine learning to existing luminescence detection is a predictable technological enhancement that a PHOSITA would consider an obvious optimization of radiation therapy monitoring techniques
Source Patent Element
Ion beam radiation targeting method
PTD Variation
IoT-enabled sensor network for real-time radiation dosage tracking and adjustment
Obviousness Reasoning
Integrating real-time monitoring technologies with existing radiation delivery methods represents a standard approach to improving medical treatment precision and safety
Source Patent Element
Skin marker placement for radiation targeting
PTD Variation
Blockchain-based patient treatment record management system
Obviousness Reasoning
Implementing secure digital record management for medical procedures is a known technique for improving data integrity and patient care tracking
Source Patent Element
Cancer treatment radiation methodology
PTD Variation
Personalized treatment planning using patient-specific anatomical and tumor characteristic analysis
Obviousness Reasoning
Developing individualized treatment approaches through computational analysis is a predictable evolution of standard medical treatment optimization strategies
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857806 and the disclosed technological variations, a person of ordinary skill in the art would find the proposed radiation therapy system modifications to be obvious combinations of known techniques. The incremental technological integrations represent predictable extensions of existing ion beam radiation therapy methodologies, thereby rendering potential derivative claims obvious and unpatentable under standard obviousness analysis.

Original Patent Information

Patent NumberUS 11,857,806
TitleLuminescence-based method for precise delivery of ion beam therapy
Assignee(s)United States of America as represented by the Secretary of the Navy